• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS Biol . In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age

tetano

Editor, Senior Moderator
PLoS Biol


. 2020 Sep 8;18(9):e3000849.
doi: 10.1371/journal.pbio.3000849. eCollection 2020 Sep.
In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age


Nicole A P Lieberman[SUP] 1 [/SUP], Vikas Peddu[SUP] 1 [/SUP], Hong Xie[SUP] 1 [/SUP], Lasata Shrestha[SUP] 1 [/SUP], Meei-Li Huang[SUP] 1 [/SUP], Megan C Mears[SUP] 2 3 [/SUP], Maria N Cajimat[SUP] 2 3 [/SUP], Dennis A Bente[SUP] 2 4 [/SUP], Pei-Yong Shi[SUP] 2 5 [/SUP], Francesca Bovier[SUP] 6 [/SUP], Pavitra Roychoudhury[SUP] 1 7 [/SUP], Keith R Jerome[SUP] 1 7 [/SUP], Anne Moscona[SUP] 6 8 9 10 [/SUP], Matteo Porotto[SUP] 6 8 11 [/SUP], Alexander L Greninger[SUP] 1 7 [/SUP]



Affiliations

Abstract

Despite limited genomic diversity, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has shown a wide range of clinical manifestations in different patient populations. The mechanisms behind these host differences are still unclear. Here, we examined host response gene expression across infection status, viral load, age, and sex among shotgun RNA sequencing profiles of nasopharyngeal (NP) swabs from 430 individuals with PCR-confirmed SARS-CoV-2 and 54 negative controls. SARS-CoV-2 induced a strong antiviral response with up-regulation of antiviral factors such as OAS1-3 and IFIT1-3 and T helper type 1 (Th1) chemokines CXCL9/10/11, as well as a reduction in transcription of ribosomal proteins. SARS-CoV-2 culture in human airway epithelial (HAE) cultures replicated the in vivo antiviral host response 7 days post infection, with no induction of interferon-stimulated genes after 3 days. Patient-matched longitudinal specimens (mean elapsed time = 6.3 days) demonstrated reduction in interferon-induced transcription, recovery of transcription of ribosomal proteins, and initiation of wound healing and humoral immune responses. Expression of interferon-responsive genes, including ACE2, increased as a function of viral load, while transcripts for B cell-specific proteins and neutrophil chemokines were elevated in patients with lower viral load. Older individuals had reduced expression of the Th1 chemokines CXCL9/10/11 and their cognate receptor CXCR3, as well as CD8A and granzyme B, suggesting deficiencies in trafficking and/or function of cytotoxic T cells and natural killer (NK) cells. Relative to females, males had reduced B cell-specific and NK cell-specific transcripts and an increase in inhibitors of nuclear factor kappa-B (NF-κB) signaling, possibly inappropriately throttling antiviral responses. Collectively, our data demonstrate that host responses to SARS-CoV-2 are dependent on viral load and infection time course, with observed differences due to age and sex that may contribute to disease severity.
 
Back
Top Bottom